2008 Midyear Clinical Meeting
Click here to go to the previous page
Oncology Pharmacy Specialty Sessions 2008: Advanced Topics in Practice, Part I
Track:
Educational Sessions
Program Code: 283-L01
Date: Tuesday, December 9, 2008
Time: 8:00 AM to 11:00 AM EST
Location:
S230H
MEETING PLANNING ASSOCIATE:
Dr. Mark Geraci, PharmD, BCOP, Pharmacy Benefits Management Strategic Healthcare Group (119D)
PRESENTER(S):
Dr. Mark Geraci, PharmD, BCOP, Pharmacy Benefits Management Strategic Healthcare Group (119D)
|
Dr. Goldspiel is Deputy Chief and Program Director of the Specialized Residency in Oncology Pharmacy Practice. He received his B.S. in Pharmacy from the Arnold and Marie Schwartz College of Pharmacy and a Pharm.D. degree from the University of Texas Health Science Center at San Antonio. He completed a Specialized Residency in Oncology Pharmacy Practice at the Audie Murphy Veterans Hospital in San Antonio. He has Clinical Assistant Professor appointments in Schools of Pharmacy at Howard University, University of Maryland, Albany University, and Idaho State University. He is Editor of the Journal of Oncology Pharmacy Practice, the official publication of the International Society of Oncology Pharmacy Practitioners (ISOPP). He is also a past-President and Fellow of ISOPP. He is a founding member and past-President of HOPA.
|
|
Donald Harvey is Director of the Phase I Program and Assistant Professor of Hematology and Oncology at the Winship Cancer Institute of Emory University in Atlanta.
Dr. Harvey received his BS in pharmacy and PharmD from the University of North Carolina. He completed a practice residency at the University of Kentucky followed by a hematology/oncology specialty residency at UNC. He has authored review articles and textbook chapters and frequently lectures on hematologic malignancies. His research interests include novel target inhibition of molecular pathways of tumorigenesis and individualized therapy through pharmacokinetic, pharmacodynamic, and pharmacogenomic endpoint application.
|
Mary Lynn McPherson,
PharmD, BCPS, Professor and Vice Chair,
University of Maryland School of Pharmacy
|
Mary Lynn McPherson, Pharm.D., BCPS, is Professor and Vice Chair in the Department of Pharmacy Practice and Science at the University of Maryland School of Pharmacy in Baltimore. She serves as a consultant pharmacist for both local and national hospice and palliative care programs, and has designed a critical thinking process for appropriate drug use in end of life patients. She serves on the Boards of the Hospice Network of Maryland and the Maryland Pain Initiative. McPherson is also the Chairman of the Board of the American Society of Pain Educators. Dr. McPherson teaches extensively in the Pharm.D. curriculum on pain management and end of life care, including didactic and experiential content. McPherson also serves as a primary care pharmacist and Director of Pharmacotherapy Services at UniversityCare Waxter in Baltimore. She also developed one of the first and few palliative care pharmacy residencies in the U.S. McPherson is a Fellow in the American Pharmacists Association, American Society of Health-Systems Pharmacists and American Society of Consultant Pharmacists. She has received many honors for her work, including the American Pharmacists Association Distinguished Achievement Award in Specialized Practice, the Maryland Pharmacists Association Innovative Practice Award, and the Maryland Society of Health-Systems Pharmacists W. Purdum Lifetime Achievement Award. She has written three books, and many chapters and peer-reviewed articles on pain management, palliative care, and other topics.
|
- Describe the current standard of care for a patient with advance prostate cancer.
- Discuss novel treatment in myelodysplastic syndromes.
- Discuss state of the art treatment algorithms for CML and distinguish between the roles of imatinib and second-generation therapies for treatment of CML.
